Shopping Cart
Remove All
Your shopping cart is currently empty
Gremubamab (MEDI3902) is a humanised monoclonal antibody targeting PcrV/Psl, exhibiting bivalent and bispecific properties. It binds to both the PAPcrV protein and Psl extracellular polysaccharide, making it suitable for studying Pseudomonas aeruginosa infections.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $463 | - | In Stock | |
| 5 mg | $1,180 | - | In Stock | |
| 10 mg | $1,920 | - | In Stock | |
| 25 mg | $2,850 | - | In Stock | |
| 50 mg | $3,830 | - | In Stock |
| Description | Gremubamab (MEDI3902) is a humanised monoclonal antibody targeting PcrV/Psl, exhibiting bivalent and bispecific properties. It binds to both the PAPcrV protein and Psl extracellular polysaccharide, making it suitable for studying Pseudomonas aeruginosa infections. |
| In vivo | Gremubamab (1, 5, 15 mg/kg, intravenous injection, administered 1 hour post-infection) exhibited protective effects in a rabbit model of acute pneumonia, improving survival rates [2]. |
| Synonyms | MEDI3902, MEDI 3902 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 1800381-36-5 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.